NXTC earnings: a positive outcome, +8.8%

On May 2, 2024, NextCure, Inc. reached its earnings. The result was a positive outcome, and the stock moved +8.8% in the window around the event. It had already run -53.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.